Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.

ABSTRACT:

Importance

Most prisons and jails in the US discontinue medications for opioid use disorder (MOUD) upon incarceration and do not initiate MOUD prior to release.

Objective

To model the association of MOUD access during incarceration and at release with population-level overdose mortality and OUD-related treatment costs in Massachusetts.

Design, setting, and participants

This economic evaluation used simulation modeling and cost-effectiveness with costs and quality-adjusted life-years (QALYs) discounted at 3% to compare MOUD treatment strategies in a corrections cohort and an open cohort representing individuals with OUD in Massachusetts. Data were analyzed between July 1, 2021, and September 30, 2022.

Exposures

Three strategies were compared: (1) no MOUD provide

SUBMITTER: Chatterjee A 

PROVIDER: S-EPMC10105308 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature